XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 146,256 $ 102,562
Short-term investments 0 5,000
Accounts receivable, net 14,657 9,680
Inventories 1,762 3,354
Prepaid expenses 5,082 4,828
Other current assets 11,042 2,188
Total current assets 178,799 127,612
Property and equipment, net 1,371 1,297
Operating lease right-of-use assets 2,722 3,414
Intangible assets, net 50,625 55,297
Goodwill 21,208 21,208
Other assets 2,758 240
Total assets 257,483 209,068
Current Liabilities    
Accounts payable 6,091 9,615
Accrued expenses 29,993 9,102
Accrued litigation settlement 15,000 63,421
Operating lease liabilities 1,265 1,212
Contingent royalty obligation payable to Evolus Founders 5,314 3,446
Promissory note payable to Evolus Founders 0 19,068
Term loan, net of discount and issuance costs 0 74,384
Total current liabilities 57,663 180,248
Accrued litigation settlement 5,000 20,000
Operating lease liabilities 2,256 3,147
Contingent royalty obligation payable to Evolus Founders 39,426 38,100
Term loan, net of discount and issuance costs 71,222 0
Convertible note 0 40,506
Deferred tax liability 40 25
Total liabilities 175,607 282,026
Commitments and contingencies
Stockholders’ equity (deficit)    
Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 0 0
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 55,576,988 and 33,749,228 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 1 1
Additional paid-in capital 504,757 303,113
Accumulated deficit (422,882) (376,072)
Total stockholders’ equity (deficit) 81,876 (72,958)
Total liabilities and stockholders’ equity (deficit) $ 257,483 $ 209,068
Common stock, shares authorized (in shares) 100,000,000 100,000,000